Table 2.
Assessment of kidney function in PCOS and control subjects.
| Characteristic | Control (N = 69) | PCOS (N = 55) | P‐value |
|---|---|---|---|
| SCr (μmoI/L) | 53.87 ± 7.87 | 54.69 ± 8.87 | 0.587 |
| BUN (mmol/L) | 4.26 ± 0.97 | 4.14 ± 1.10 | 0.523 |
| UACR (mg/g) | 8.47 ± 7.31 | 13.77 ± 17.10 | 0.043* |
| KapU (μg/mg) | 9.38 ± 7.34 | 10.51 ± 11.22 | 0.499 |
| LamU (μg/mg) | 5.17 ± 4.06 | 5.48 ± 5.26 | 0.708 |
| α1‐MU (μg/mg) | 7.33 ± 5.39 | 7.80 ± 6.72 | 0.661 |
| β2‐MU (μg/mg) | 0.29 ± 0.23 | 0.30 ± 0.24 | 0.876 |
| UACR> 7mg/g | 44.93% | 45.45% | 0.953 |
SCr, Serum creatinine; BUN, blood urea nitrogen; UACR, urinary albumin to creatinine ratio; KapU, human immunoglobulin/light chain κ‐type; LamU, human immunoglobulin/light chain λ‐type; α1‐MU, α1‐Microglobulin; β2‐MU, β2‐Microglobulin.
* indicates P < 0.05